In November 2026, the Centers for Medicare & Medicaid Services (CMS) issued the CY 2027 Medicare Physician Fee Schedule (PFS) Final Rule, effective January 1, 2027. The rule updates Medicare Part B payment policies, relative value units (RVUs), quality reporting requirements, and other Medicare programs.
For wound care and hyperbaric oxygen treatment (HBO₂) practices, the most relevant provisions involve modifier-25 reimbursement, practice expense methodology, quality reporting, skin substitutes, telehealth flexibilities, remote monitoring requirements, and the replacement of HCPCS G2211.
The regulations are effective January 1, 2027.
Key takeaways for wound care and HBO₂ practices
- The CY 2027 PFS final rule establishes updated work, practice expense (PE), and malpractice (MP) relative value units (RVUs).
- Conversion factors: CMS estimates CY 2027 conversion factors of:
- $32.9548 for qualifying Alternative Payment Model (APM) participants
- $32.6286 for nonqualifying APM participants
- These reflect separate statutory update factors of 0.75 percent and 0.25 percent, respectively, along with a −0.12 percent budget-neutrality adjustment.
- Modifier -25 and 0-day global procedures: CMS finalized a 20 percent reduction to all but the highest-paid service when a separately identifiable office/outpatient evaluation/management (E/M) service is reported with modifier -25 on the same day as a 0-day global procedure. This is particularly relevant to wound care practices that perform procedures and same-day E/M services.
- Replacement for G2211: CMS replaced HCPCS G2211 with:
- Modifier B1, valued at 16 percent of the total E/M RVUs
- Modifier B2, valued at 32 percent of the total E/M RVUs for services furnished in an accountable care organization (ACO)
- HBO₂: CMS preserved separate reporting for physician supervision (CPT 99183) and the hyperbaric treatment-delivery component (HCPCS G0277).
- Cellular, Acellular, and Matrix-Like Products (CAMPs)/ Cellular and/or tissue based products (CTP)/ Skin substitutes: CMS finalized a national payment rate of $127.14 per cm² for non-sheet-form skin substitutes, consistent with the rate for sheet-form products.
- For non-sheet products, cm² represents the treated wound surface area rather than necessarily the product’s physical dimensions.
- Non-sheet products are paid in the office and packaged in the hospital.
- Real-time fluorescence wound imaging: CMS finalized national payment and practice expense policies for CPT 97611.
- The code remains excluded from skilled nursing facilities (SNF) consolidated billing because CMS did not designate it as a sometimes therapy service.
- Facility-setting direct PE inputs were not assigned because those costs are accounted for under non-PFS payment systems.
- Local Medicare Administrative Contractor (MAC) policies govern coverage for this technology. If the MACs finalize their proposed noncoverage policies, claims billed under the nationally priced code would be denied in the affected jurisdictions for failing to meet Medicare’s reasonable and necessary standard.
- Low-frequency ultrasound wound therapy: CMS reduced the direct practice-expense (PE) supply input for CPT 97610 from $320.18 to $125. For non-facility care setting, CMS proposed a total RVU of 9.6471, which multiplied by the applicable 2027 conversion factor, produces a proposed national average payment of $314.54 for CPT 97610.
- Telehealth: CMS finalized continued telehealth flexibilities through the applicable statutory periods, added services to the Medicare Telehealth Services List, revised critical-care telehealth descriptors, and established new telehealth modifiers effective January 1, 2027.
- Remote monitoring: CMS finalized requirements for remote physiologic and remote therapeutic monitoring, including an initiating face-to-face visit, established-patient requirements for Remote Therapeutic Monitoring (RTM), and a delayed transition to direct employment of clinical staff beginning January 1, 2029.
- Quality reporting: CMS finalized additional changes to MIPS, MIPS Value Pathways (MVPs), and the APM Performance Pathway (APP), including updates to quality measures, MIPS core-measure reporting, and the APP Plus framework.
2027 CMS PFS Finalized Policies Relevant to Wound Care Practices
PFS Payment Updates and Conversion Factors
The PFS determines payment using RVUs for three resource categories:
- Physician work
- Practice expense (PE)
- Malpractice expense
These RVUs are adjusted geographically and multiplied by a conversion factor.
- For CY 2027, CMS estimates the following conversion factors:
- Qualifying APM participants: $32.9548
- Non-qualifying APM participants: $32.6286
- The estimates incorporate removal of the one-year 2.5% CY 2026 statutory increase, the applicable 2027 update factors and budget neutrality.
- Actual payment for a wound care or HBO₂ service will continue to depend on the applicable code, RVUs, geographic practice cost indices, place of service, modifiers, and other claim-specific factors.
RVUs and Practice Expense
CMS finalized CY 2027 RVU updates reflecting clinical practice changes, resource utilization, and statutory mandates.
- Key adjustments include:
- New and revised code valuations
- Potentially misvalued code reviews
- Updates to physician work time
- Revisions to direct practice expense inputs
- Changes affecting indirect practice expense allocation
- CMS noted that adjustments to work time directly affect direct PE inputs. The agency reviewed equipment time and other direct inputs to resolve discrepancies and align work values with practice expense assumptions.
- Specialty-level financial impacts will vary based on service mix and volume, meaning actual revenue changes for individual practices may differ from CMS projections.
Modifier -25: Important Change for Wound Clinics
- CMS finalized a policy reducing payment to all but the highest-paid service by 20% when:
- A separately identifiable office/outpatient E/M visit is furnished by the same physician, or a physician of the same specialty in the same group practice;
- The E/M service is furnished on the same day as a 0-day global procedure; and
- Modifier -25 is reported.
- The policy is narrower than the proposed approach. The proposal would have included procedures with 0-, 10-, and 90-day global periods and applied a larger 50% reduction.
- The final policy:
- Applies only to 0-day global services
- Reduces payment by 20%, rather than 50%
- CMS estimates that the impacts to specialties will be reduced by around 1% by limiting this policy to only 0-day global services, rather than 0-, 10-, and 90-day global services as proposed.
- Wound care practices may also be impacted when performing 0-day global procedures alongside E/M visits, with actual revenue effects depending on their specific procedure mix, coding habits, and site-of-service distribution.
Operational considerations regarding modifier-25 for wound care practices
- Consider reviewing workflows for encounters involving:
- Debridement and a separately identifiable E/M service
- Other 0-day global procedures performed during an office visit
- Multiple procedures and E/M services furnished on the same date
- Documentation supporting the separate and significant nature of the E/M service
- Practices should ensure that documentation supports the clinical distinction between the procedure and the E/M service when modifier -25 is reported. Billing and compliance teams should also evaluate how the policy affects expected reimbursement and claims-edit logic beginning January 1, 2027.
Replacement of G2211 With Modifiers B1 and B2
- HCPCS code G2211 is an add-on code for the visit complexity inherent to certain evaluation and management (E/M) services. It recognizes medical care that:
- Serves as the continuing focal point for all needed health care services; and/or
- Is part of ongoing care related to a patient’s single serious condition or complex condition.
- CMS finalized replacement of HCPCS code G2211 with modifiers:
- B1: 16% of the total RVUs for the E/M service
- B2: 32% of the total RVUs for the E/M service when the service is furnished in an ACO
- CMS expects the overall impact of replacing G2211 to be limited because the utilization previously reported under G2211 was incorporated into the payment modeling.
- Practices participating in an ACO should evaluate how modifier B2 applies to eligible E/M services and ensure that billing systems, staff education, and internal coding guidance are updated before January 1, 2027.
Wound care and HBO₂ code-level payment considerations
- The CY 2027 PFS Final Rule establishes updated payment policies and resource inputs.
- For specific RVUs, work/practice expense values, or exact reimbursement amounts for wound care or HBO₂ codes, practices should consult CMS public-use files, including Addendum B, direct practice expense input files, physician work-time files, specialty impact files, and MAC billing guidance.
Hyperbaric Oxygen Treatment (HBO₂) Updates
- CMS did not finalize a change to the existing two-code reporting structure for HBO2:
- CPT 99183 reports the physician’s attendance and supervision during HBO₂ treatment.
- HCPCS G0277 reports the resources required to deliver the treatment, including the hyperbaric chamber, oxygen-delivery and monitoring systems, trained ancillary staff, and related safety and maintenance requirements.
- CMS retained G0277 as a distinct code and preserved separate reporting of CPT 99183 and G0277.
Skin Substitute Payment Policy
CMS finalized a national payment methodology for non-sheet-form skin substitutes beginning in CY 2027. The policy applies the same rate used for sheet-form skin substitutes: $127.14 per cm².
Non-sheet products
- In the CY 2026 PFS Final Rule, CMS had finalized contractor pricing for non-sheet products because the units used to describe these products (such as milliliters, cubic centimeters, and milligrams) were difficult to standardize.
- For CY 2027, CMS finalized national pricing for non-sheet products on a per-cm² basis, concluding that the resource costs per cm² are consistent with those of sheet-form products.
- CMS clarified that:
- The per-cm² rate is based on the wound surface area treated, not the physical dimensions of the product.
- A product does not need to be packaged or marketed in square-centimeter units.
- Existing HCPCS descriptors will remain in place, even when they describe products using units such as mL, cc, or mg.
- Differences in wound depth, volume, or product form do not, by themselves, require a separate payment methodology.
- The finalized national payment rate is $127.14 per cm²
- Application codes G0681–G0684
- CMS also finalized national payment for the non-sheet skin substitute application codes G0681–G0684, consistent with the approach used for sheet-form application codes CPT 15271–15278.
- These codes are designated for non-sheet-form skin substitute products and are reported according to wound surface area.
- The finalized work RVUs are:
- G0681: First 25 cm² or less, for wounds up to 100 cm² : 1.46
- G0682: Each additional 25 cm², or part thereof, for wounds up to 100 cm²: 0.32
- G0683: First 100 cm², for wounds ≥100 cm²: 3.41
- G0684: Each additional 100 cm², or part thereof, for wounds ≥100 cm²: 0.78
Sheet products
- CMS maintained current policies for sheet-form skin substitutes, preserving:
- Payment rates for sheet-form products.
- The rate calculation and update methodology.
Operational considerations regarding skin substitutes for wound care practices
- A non-sheet product is paid in the office and packaged in the hospital.
- Confirm which products are classified as sheet-form versus non-sheet-form.
- Review the CMS list of non-sheet skin substitute products.
- Update billing systems for the national payment methodology and codes G0681–G0684.
- Ensure documentation supports the treated wound surface area.
- Avoid assuming that a product must be packaged or labeled in cm² to be paid using the per-cm² methodology.
- Review Medicare Administrative Contractor guidance and the final CY 2027 fee schedule for implementation details.
Real-Time Fluorescence Wound Imaging
CMS finalized CPT 97611 for real-time fluorescence wound imaging in clinical darkness to identify bacterial presence, location, and load and to measure wound size, reported per day.
- The code retains a 0.80 work RVU and 26 minutes of physician time—6 minutes pre-service, 15 minutes intraservice, and 5 minutes immediate post-service—and will receive national pricing and be subject to the OPPS cap.
- CMS finalized nonfacility direct PE inputs based largely on CPT 97610, including 42 minutes of clinical labor and the ER131 real-time fluorescence wound imaging system, while removing supply items SF007 and SJ046.
- Reporting with debridement: CMS did not establish a specific concurrent-billing policy with debridement but retained the separate direct PE inputs after commenters explained that imaging supports clinical decision-making and is distinct from tissue removal.
- CMS noted that concurrent billing may become more common as adoption increases; predecessor codes 0598T and 0599T were billed with wound debridement codes 35.1% and 46.6% of the time, respectively. This does not establish that CPT 97611 is automatically payable whenever billed with debridement; claims remain subject to applicable Medicare coverage, coding, and documentation requirements.
Operational considerations regarding real-time fluorescence imaging for wound care practices
- Of note, Medicare’s national payment rate applies when a service is covered. Local Medicare Administrative Contractor (MAC) policies govern coverage for this technology. If the MACs finalize their proposed noncoverage policies, claims billed under the nationally priced code would be denied in the affected jurisdictions for failing to meet Medicare’s reasonable and necessary standard.
- If the MACs determine that this is a covered technology, consider updating billing for CPT 97611, ensure clear medical documentation for separate imaging and debridement, and monitor MAC coverage guidelines.
Low-Frequency, Non-Contact, Non-Thermal Ultrasound Wound Therapy
- CMS finalized updates to CPT code 97610 due to the direct practice-expense valuation of supply code SA119, the kit for low-frequency ultrasound wound therapy.
- Practice-expense (PE) RVU:
- CMS finalized an SA119 price of $125, rather than the proposed $100, because $125 was the most commonly cited cost in commenter feedback. CMS stated that the current $320.18 price was not supported by the information submitted and appeared overvalued.
- CMS also finalized addition of 1 quantity of SH069 (sodium chloride 0.9% irrigation (500-1000ml) to CPT code 97610 in the non-facility setting.
- Work RVU: No changes. CMS solicited comments on whether physician time was overstated but finalized no changes to CPT 97610’s physician time, work RVU, or clinical labor time.
- As a result, for CY 2027, CPT code 97610 total RVUs are:
- Total Non-Facility RVU: 9.64 or $314.54 (a ~19% decrease from CY 2026)
- Total Facility RVU: 0.46 (a ~2% decrease from CY 2026)
Operational considerations regarding low-frequency, non-contact, non-thermal ultrasound for wound care practices
- Practices should review the CY 2027 direct practice expense files and Addendum B for the finalized CPT 97610 RVUs and payment information.
Autologous platelet-rich plasma (PRP)
HCPCS G0465 reports autologous platelet-rich plasma (PRP) or another blood-derived product for diabetic chronic wounds or ulcers, using an FDA-cleared device for this indication. The code includes applicable administration, dressings, phlebotomy, centrifugation or mixing, and other preparatory procedures and is reported per treatment.
- CMS considered requests to:
- Increase the physician work RVU from 1.78 to 5.50, based on a Fall 2025 survey.
- Exempt G0465 from multiple-procedure payment adjustments.
- Reevaluate the existing crosswalk to CPT 15275.
- After reviewing public comments and additional survey information, CMS finalized nominating G0465 as potentially misvalued for future review (no current changes).
Skin Cell Suspension Autograft (SCSA)
- CMS finalized four new CPT codes for SCSA:
- 15006: Trunk, arms, and/or legs; first 100 cm² or less, or 1% of body area in infants and children.
- 15007: Each additional 100 cm², or each additional 1% of body area in infants and children, or part thereof.
- 15008: Face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; first 100 cm² or less, or 1% of body area in infants and children.
- 15009: Each additional 100 cm², or each additional 1% of body area in infants and children, or part thereof.
- The existing eight SCSA codes, including CPT 15018, were deleted, and the SCSA guidelines were revised.
- CMS finalized the RUC-recommended work RVUs without changes:
- 15006: 10.97
- 15007: 0.59
- 15008: 11.28
- 15009: 0.98
Telehealth Updates
- CMS finalized several CY 2027 telehealth changes, including:
- Extended flexibilities through December 31, 2027: Removal of geographic restrictions, expanded originating sites, and eligibility for occupational therapists, physical therapists, speech-language pathologists, and audiologists.
- Audio-only telehealth: Flexibility extended through January 1, 2028, subject to applicable requirements.
- Mental health telehealth: In-person visit requirements remain delayed through December 31, 2027.
- New telehealth modifiers: Modifiers BB and BC are required beginning January 1, 2027:
- BB: Services furnished through a virtual platform owned by, or used under a payment arrangement with, another entity.
- BC: Services furnished incident to a physician’s or practitioner’s professional service.
- These modifiers do not affect payment.
- Medicare Telehealth Services List: CMS added the following codes to the CY 2027 Medicare Telehealth Services List:
- G0572. Advance care planning by clinical staff, first 20 minutes.
- G0573. Advance care planning by clinical staff, each additional 20 minutes.
- G0576. Outpatient E/M for vaccine adverse effects, each 15 minutes.
- G0686. Group-based medical session (2–10 patients), first 60 minutes.
- G0687. Group-based medical session, each additional 30 minutes.
- G0903. Individual speech, language, voice, or auditory processing therapy, pediatric (age 21 and under).
- CMS also added replacement codes for deleted CPT codes 92507, 0362T, and 0373T, including speech-language pathology codes 92654–92663 and adaptive behavior service codes 97148, 97149, 97159, 97160, and 97173.
- CMS revised the descriptors for critical care telehealth codes G0508 and G0509 to reflect permanent removal of frequency limitations. Teaching physicians may also bill services involving residents when either the teaching physician or resident is in the same physical location as the beneficiary.
Operational considerations regarding telehealth for wound care practices
- Practices should update billing systems for modifiers BB and BC, confirm applicable telehealth-list codes and audio-only requirements, and monitor CMS guidance for implementation.
Remote Monitoring Services
- CMS finalized new requirements for remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM) beginning in CY 2027:
- Initiating visit: RPM and RTM must be initiated during a separately reportable face-to-face visit, which may be in person or via telehealth. The services must be discussed during the visit, but they do not need to be the visit’s sole purpose.
- Established patients: RTM must be furnished only to established patients. CMS uses the existing PFS definition of an established patient. Patients already receiving remote monitoring before January 1, 2027, do not need a new initiating visit to continue, provided all other requirements are met.
- Third-party staffing: CMS delayed the employee-only requirement by two years. Through December 31, 2028, practices may continue using third-party companies, but all incident-to requirements, practitioner oversight, and clinical integration requirements must be met. Beginning January 1, 2029, RPM and RTM cannot be billed when clinical staff are not direct employees of the billing practitioner or practice.
- Program integrity: CMS cited concerns about fragmented care, insufficient practitioner oversight, and potential fraud, waste, and abuse. The billing practitioner must retain meaningful involvement in the services.
- CMS also finalized new or revised RPM and RTM codes for monitoring periods of 2–15 days and 16–30 days, as well as updated treatment-management codes.
Quality Payment Program and MIPS
CMS finalized changes to the Quality Payment Program (QPP) beginning with the CY 2027 performance period/2029 payment year. The QPP continues to include two participation tracks. Each has their own reporting options:
- Merit-based Incentive Payment System (MIPS)
- Reporting options are:
- Traditional MIPS
- MIPS Value Pathways (MVPs)
- Alternative Payment Model Performance Pathway (APP)
- Advanced Alternative Payment Models (Advanced APMs), such as accountable care organizations (ACOs)
- Within an advanced APM, relevant statuses are:
- Qualifying APM Participant (QP): The clinician is excluded from MIPS reporting requirements and MIPS payment adjustments and receives the applicable enhanced conversion-factor update.
- Partial QP: The clinician may elect to participate in MIPS. If the clinician elects MIPS participation, they are subject to MIPS reporting requirements and payment adjustments.
- QP and Partial QP determinations are applied at the TIN/NPI level under the finalized policy.
Merit-based Incentive Payment System (MIPS)
- Qualifying APM Participants (QP) are completely exempt from MIPS reporting and are safe from any MIPS penalties.
- Non-QPs must report data via MIPS, facing up to a +/-9% payment adjustment.
- CMS estimates that there are:
- 586,925 MIPS-eligible clinicians
- Approximately $51.70 billion in associated funds Medicare agrees to pay for all covered services provided under this program.
- There continues to be three MIPS reporting options:
- Traditional MIPS
- MIPS Value Pathways (MVPs)
- Alternative Payment Model Performance Pathway (APP)
Evolution toward MIPS Value Pathways (MVPs)
CMS finalized a transition away from traditional MIPS to MVP as the primary participation framework for the clinicians. The sunset date was delayed from CY 2029 to CY 2031 to allow additional time to expand MVP availability, refine MVP policies, and support the transition to digital reporting.
- MVP updates for 2027 include:
- MIPS core measures: CMS finalized the requirement to include MIPS core measures across MVPs. Beginning with CY 2027, MVPs include designated MIPS core measures, and eligible clinicians reporting an MVP must report at least one applicable core measure. If no applicable core measure is available, the clinician must attest to that and report another non-core measure. Small-practice clinicians are exempt from this core-measure requirement.
- Three new MVPs: CMS finalized the Diabetic Disease MVP, Hospitalist MVP, and Hypertension MVP, as proposed.
Finalized CY 2027 MIPS Performance Category, Quality Measure, and Improvement Activity Updates
- Performance-category weights: Finalized as proposed:
- Quality: 30%
- Cost: 30%
- Promoting Interoperability: 25%
- Improvement Activities: 15%
- Note: These weights apply to MIPS final-score calculations, including traditional MIPS and MVP reporting, unless a specific regulatory exception or alternate scoring rule applies. The APP has separate reporting and scoring requirements.
- MIPS quality-measure inventory: Finalized at 180 measures for CY 2027, including:
- 10 new measures
- 20 measure removals
- 43 substantive changes to existing measures
- High-priority designation: Finalized for removal. CMS replaced the prior requirement to report one outcome measure—or one high-priority measure when an outcome measure was unavailable—with a requirement to report at least one applicable MIPS core measure. If no applicable core measure is available, the clinician must attest to that and report another non-core measure. Small-practice clinicians are exempt from this core-measure requirement.
- Improvement Activities Inventory: Finalized as proposed:
- Six new improvement activities
- Five modified activities
- Eleven removed activities
- Creation of the Advancing Health and Wellness subcategory
- The new activities include initiatives involving care coordination, workflow and diagnostic performance, nutrition and other health-impacting nonclinical issues, advance-care planning, clinician use of artificial intelligence, and lifestyle approaches to diabetes remediation.
CY 2027 MIPS Quality-Reporting Requirements
- Beginning with the CY 2027 performance period (2029 payment year), CMS replaced the outcome/high-priority measure requirement with a mandate to report at least one MIPS core measure.
- Traditional MIPS:
- Clinicians reporting traditional MIPS must submit data on at least six quality measures (or all applicable measures if fewer than six exist), including at least one applicable MIPS core measure. If no core measure is available, clinicians must attest and select another measure.
- Clinicians using a specialty measure set lacking an applicable core measure must also attest and select an alternate measure within that set.
- Small practices are exempt from the core-measure requirement and attestation. They must still report six applicable measures if available, but core-measure inclusion is voluntary.
- MIPS Value Pathways (MVPs):
- MVP participants must select at least four quality measures within their MVP (excluding the required population-health measure), including at least one core measure. If no core measure is available within the MVP, clinicians must attest and choose another measure from that MVP.
- Small-practice MVP participants are exempt from the core-measure requirement and attestation, though they must still report four applicable MVP measures.
- Failing to report a required MIPS core measure or submit the attestation will result in zero achievement points for one quality measure across both traditional MIPS and MVP options.
Advanced Alternative Payment Models (Advanced APMs) Incentives
- Under the finalized framework, eligible clinicians who participate in an Advanced APM) and achieve Qualifying APM Participant (QP) status remain exempt from MIPS reporting requirements and MIPS payment adjustments. Partial QPs may elect to participate in MIPS; if they do, they are subject to MIPS reporting requirements and payment adjustments.
- Beginning with the 2024 performance year/2026 payment year, Medicare uses two separate physician fee schedule conversion factors:
- Qualifying APM conversion factor: 0.75% annual update
- Nonqualifying APM conversion factor: 0.25% annual update
- These updates produce an approximately 0.5 percentage-point annual difference between the two conversion-factor updates.
- For CY 2027, CMS estimates the conversion factors at $32.9548 for QPs and $32.6286 for non-QPs.
- CMS also finalized applying QP and Partial QP status at the TIN/NPI level, with a modification for clinicians who achieve status through an individual-level determination.
For wound care clinicians, Advanced APM participation may provide MIPS relief and higher payment updates—but only when the clinician meets the requirements for QP or Partial QP status. Participation therefore represents a potential payment and administrative advantage, rather than an automatic incentive for every Advanced APM participant.
CY 2027 Medicare Fee Schedule: Action Steps for Wound Care Practices
Checklist for wound care and HBO2 programs, to be completed before January 1, 2027:
- 1. Review CY 2027 RVUs for all wound care, debridement, E/M, and related services.
- 2. Model the conversion-factor changes using actual historical utilization.
- 3. Assess modifier -25 exposure, particularly for E/M services billed with 0-day global procedures.
- 4. Update billing and EHR systems for modifiers B1 and B2, and other finalized coding and payment policies.
- 5. Confirm ACO, APP, APP Plus, MVP, and traditional MIPS reporting obligations for each clinician or reporting entity.
- 6. Review applicable CY 2027 MIPS quality-measure specifications and MVP inventories.
- 7. Update compliance education on documentation supporting separately identifiable E/M services.
- 8. Examine direct practice expense inputs for supplies, clinical labor, equipment, and procedure-room resources.
- 9. Use CMS’s PFS CY 2027 Addendum B, direct practice-expense files, and other public-use files for code-level payment analysis.
- 10. Coordinate with Medicare Administrative Contractors and clearinghouses regarding implementation instructions when available.
Bottom Line
The CY 2027 PFS Final Rule introduces important operational and financial considerations for wound care and HBO₂ practices.
Key provisions include updated conversion factors, revised RVUs and practice expense inputs, the 20% reduction for same-day E/M claims involving 0-day global procedures with modifier -25, and the replacement of G2211 with modifiers B1 and B2. Additionally, when applicable, practices must adapt to national pricing for non-sheet skin substitutes, new telehealth modifiers (BB and BC), updated remote monitoring requirements, and payment updates for fluorescence imaging and low-frequency, non-contact, non-thermal ultrasound wound therapy.
Because the provided rule summary does not include the finalized RVUs for individual wound care or HBO₂ codes, practices should review CMS’s CY 2027 Addendum B and supporting public-use files before finalizing reimbursement projections, fee schedules, staffing plans, and billing workflows.
Resources
Calendar Year (CY) 2027 Medicare Physician Fee Schedule Final Rule:
About the Authors
Elaine Horibe Song, MD, PhD, MBA
Dr. Song is a Co-Founder and Chief Executive Officer of WoundReference, Inc., a clinical and reimbursement decision support & telemedicine platform for wound care and hyperbaric clinicians. With a medical, science and business background, Dr. Song previously served as medical director for a regenerative medicine-focused biotech company in California, and for a Joint Commission International-accredited hospital network. Dr. Song also served as a management consultant for Kaiser Permanente, practiced as a plastic surgeon in private practice and academia, and conducted bench and clinical research in wound healing, microsurgery and transplant immunology. Dr. Song holds a position as Affiliate Professor, Division of Plastic Surgery, Federal University of Sao Paulo, and is a volunteer Communication/Website Committee, Association for the Advancement of Wound Care. She has authored more than 200 scientific publications, book chapters, software registrations and patents.
Jeff Mize, RRT, CHT, UHMSADS
With over four decades of healthcare experience, Jeff currently holds the position of Principal Partner at Midwest Hyperbaric LLC and the Co-founder and Chief Clinical Officer of Wound Reference.
Jeff has excelled in critical care throughout his career, devoting almost a decade as a Flight Respiratory Therapist/Paramedic for the Spirit of Kansas City Life Flight. In 1993, Jeff transitioned into the field of Hyperbaric Medicine and Wound Care, where he committed 21 years of his career to serving as the Program Director for a 24/7 Level 1 UHMS Accredited facility with Distinction. In this role, he continued to provide patient care while overseeing all administrative, clinical, and daily operations within the Wound Care and Hyperbaric Facility.
Jeff is a Registered Respiratory Therapist and a Certified Hyperbaric Technologist (CHT). He has also undergone training as a UHMS Safety Director and a UHMS Facility Accreditation Surveyor.
Jeff currently serves as a member of the UHMS Accreditation Council, the UHMS Accreditation Forum Expert Panel, and the UHMS Safety Committee. Additionally, he is an esteemed member of the NFPA 99 Hyperbaric and Hypobaric Facilities Technical Standards Committee.
Jeff's dedication to the field has earned him numerous prestigious awards. In 2010, he received the Gurnee Award, which honored his outstanding contributions to undersea and hyperbaric medicine. Three years later, in 2013, he was awarded the Paul C. Baker Award for his commitment to Hyperbaric Oxygen Safety Excellence. Most recently, in 2020, Jeff was honored with "The Associates Distinguished Service Award (UHMSADS)," a recognition reserved for exceptional Associate members of the Society who have demonstrated exceptional professionalism and contributions deserving of the highest accolades.
Tiffany Hamm, RN, BSN, CWS, ACHRN, UHMSADS
An Advanced Certified Hyperbaric Registered Nurse and Certified Wound Specialist with expertise in billing, coding and reimbursement specific to hyperbaric medicine and wound care services. UHMS Accreditation Surveyor and Safety Director. Principal partner of Midwest Hyperbaric LLC, a hyperbaric and wound consultative service. Tiffany received her primary and advanced hyperbaric training through National Baromedical Services in Columbia South Carolina. In 2021, Tiffany received the UHMS Associate Distinguished Service Award. "This award is presented to individual Associate member of the Society whose professional activities and standing are deemed to be exceptional and deserving of the highest recognition we can bestow upon them . . . who have demonstrated devotion and significant time and effort to the administrative, clinical, mechanical, physiological, safety, technical practice, and/or advancement of the hyperbaric community while achieving the highest level of expertise in their respective field. . . demonstrating the professionalism and ethical standards embodied in this recognition and in the UHMS mission.”